These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Impact of naringenin on oxytetracycline-mediated oxidative damage in kidney of rats. Gnanasoundari M; Pari L Ren Fail; 2006; 28(7):599-605. PubMed ID: 17050244 [TBL] [Abstract][Full Text] [Related]
23. Naringenin ameliorates streptozotocin-induced diabetic rat renal impairment by downregulation of TGF-β1 and IL-1 via modulation of oxidative stress correlates with decreased apoptotic events. Roy S; Ahmed F; Banerjee S; Saha U Pharm Biol; 2016 Sep; 54(9):1616-27. PubMed ID: 26928632 [TBL] [Abstract][Full Text] [Related]
24. A Clinically Relevant Functional Model of Type-2 Cardio-Renal Syndrome with Paraventricular Changes consequent to Chronic Ischaemic Heart Failure. Harrison JC; Smart SDG; Besley EMH; Kelly JR; Read MI; Yao Y; Sammut IA Sci Rep; 2020 Jan; 10(1):1261. PubMed ID: 31988300 [TBL] [Abstract][Full Text] [Related]
25. Senescence marker protein 30 inhibits angiotensin II-induced cardiac hypertrophy and diastolic dysfunction. Misaka T; Suzuki S; Miyata M; Kobayashi A; Ishigami A; Shishido T; Saitoh S; Kubota I; Takeishi Y Biochem Biophys Res Commun; 2013 Sep; 439(1):142-7. PubMed ID: 23933320 [TBL] [Abstract][Full Text] [Related]
26. Protective effect of naringenin against lead-induced oxidative stress in rats. Wang J; Yang Z; Lin L; Zhao Z; Liu Z; Liu X Biol Trace Elem Res; 2012 Jun; 146(3):354-9. PubMed ID: 22109809 [TBL] [Abstract][Full Text] [Related]
27. [The diagnostic value of copeptin in the cardiorenal syndrome rats and the association with heart and kidney impairment]. Sheng XS; Ding MX; Guo FM; Yu ZP; Hua X; Lin L Zhonghua Nei Ke Za Zhi; 2018 Jul; 57(7):518-521. PubMed ID: 29996272 [TBL] [Abstract][Full Text] [Related]
28. Early administration of empagliflozin preserved heart function in cardiorenal syndrome in rat. Yang CC; Chen YT; Wallace CG; Chen KH; Cheng BC; Sung PH; Li YC; Ko SF; Chang HW; Yip HK Biomed Pharmacother; 2019 Jan; 109():658-670. PubMed ID: 30404073 [TBL] [Abstract][Full Text] [Related]
29. Apela inhibits systemic and renal inflammatory reactions in mice with type I cardiorenal syndrome. Jin L; Li Q; Li J; Pan Y; Zou J; Wu X; Wang Z FASEB J; 2021 Oct; 35(10):e21907. PubMed ID: 34516679 [TBL] [Abstract][Full Text] [Related]
30. [Effects of oligomeric grape seed proanthocyanidins on isoproterenol-induced cardiac remodeling in rats]. Zuo YM; Gao S; Cao JF; Liu XY; Yu HJ; Zhang Y Yao Xue Xue Bao; 2010 May; 45(5):565-70. PubMed ID: 20931756 [TBL] [Abstract][Full Text] [Related]
31. A new animal model of cardiorenal syndrome could be established by inducing heart failure through coronary artery ligation in spontaneously hypertensive rats. Zhou B; Zhao J; Li D Sci Rep; 2024 Aug; 14(1):18732. PubMed ID: 39134654 [TBL] [Abstract][Full Text] [Related]
32. MicroRNA-21 regulates peroxisome proliferator-activated receptor alpha, a molecular mechanism of cardiac pathology in Cardiorenal Syndrome Type 4. Chuppa S; Liang M; Liu P; Liu Y; Casati MC; Cowley AW; Patullo L; Kriegel AJ Kidney Int; 2018 Feb; 93(2):375-389. PubMed ID: 28760335 [TBL] [Abstract][Full Text] [Related]
33. Effect of ginsenoside Rh1 on myocardial injury and heart function in isoproterenol-induced cardiotoxicity in rats. Gai Y; Ma Z; Yu X; Qu S; Sui D Toxicol Mech Methods; 2012 Oct; 22(8):584-91. PubMed ID: 22694660 [TBL] [Abstract][Full Text] [Related]
34. Effects of Allicin on Hypertension and Cardiac Function in Chronic Kidney Disease. García-Trejo EM; Arellano-Buendía AS; Argüello-García R; Loredo-Mendoza ML; García-Arroyo FE; Arellano-Mendoza MG; Castillo-Hernández MC; Guevara-Balcázar G; Tapia E; Sánchez-Lozada LG; Osorio-Alonso H Oxid Med Cell Longev; 2016; 2016():3850402. PubMed ID: 27990229 [TBL] [Abstract][Full Text] [Related]
35. Novel biomarkers and therapies in cardiorenal syndrome. Latini R; Aleksova A; Masson S Curr Opin Pharmacol; 2016 Apr; 27():56-61. PubMed ID: 26894469 [TBL] [Abstract][Full Text] [Related]
37. Role of inflammation in the pathogenesis of cardiorenal syndrome in a rat myocardial infarction model. Cho E; Kim M; Ko YS; Lee HY; Song M; Kim MG; Kim HK; Cho WY; Jo SK Nephrol Dial Transplant; 2013 Nov; 28(11):2766-78. PubMed ID: 24009291 [TBL] [Abstract][Full Text] [Related]
38. Combined effects of ramipril and angiotensin II receptor blocker TCV116 on rat congestive heart failure after myocardial infarction. Tao ZW; Huang YW; Xia Q; Xu QW Chin Med J (Engl); 2005 Jan; 118(2):146-54. PubMed ID: 15667801 [TBL] [Abstract][Full Text] [Related]